Thrombophilia, combined oral contraceptives and hormone replacement

被引：0
作者：
Pollak, M. [1 ]
Nagler, M. [2 ,3 ]
机构：
[1] Inselspital Univ Spital, Univ Klin Hamatol & Hamatol Zent Lab, Bern, Switzerland
[2] Inselspital Univ Spital, Univ Inst Klin Chem, Freiburgerstr, CH-3010 Bern, Switzerland
[3] Univ Bern, Freiburgerstr, CH-3010 Bern, Switzerland
来源：
GYNAKOLOGISCHE ENDOKRINOLOGIE | 2019年 / 17卷 / 03期
关键词：
Venous thromboembolism/epidemiology; Venous thromboembolism/prevention and control; Contraceptives; oral; combined/adverse effects; Estrogen replacement therapy/adverse effects; Thrombophilia/diagnosis; DEEP-VEIN THROMBOSIS; ED AMERICAN-COLLEGE; VENOUS THROMBOEMBOLISM; ANTITHROMBOTIC THERAPY; PULMONARY-EMBOLISM; RISK-ASSESSMENT; 1ST EPISODE; PROTEIN-C; DEFICIENCY; RECURRENCE;
D O I：
10.1007/s10304-019-0262-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Combined oral contraceptives (COC) and hormone replacement treatment are used by millions of women worldwide due to the reliable contraception and other health benefits they offer. Although side effects are few, the treatment puts patients at risk for venous and atrial thromboembolism. The following article describes common thrombophilic situations and risk factors for deep vein thrombosis and pulmonary embolism. The thromboembolic risk of patients treated with different types of estrogen-containing drugs is summarized and related risk factors discussed. Guidance for use in clinical practice is also provided.
引用
收藏
页码：139 / 147
页数：9
相关论文
共 29 条
[21]   Hormonal contraception and risk of venous thromboembolism: national follow-up study [J].
Lidegaard, Ojvind ;
Lokkegaard, Ellen ;
Svendsen, Anne Louise ;
Agger, Carsten .
BRITISH MEDICAL JOURNAL, 2009, 339 :557-560
[22]   International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [J].
Miyakis, S ;
Lockshin, MD ;
Atsumi, T ;
Branch, DW ;
Brey, RL ;
Cervera, R ;
Derksen, RHWM ;
De Groot, PG ;
Koike, T ;
Meroni, PL ;
Reber, G ;
Shoenfeld, Y ;
Tincani, A ;
Vlachoyiannopoulos, PG ;
Krilis, SA .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) :295-306
[23]   Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction [J].
Nagler, Michael ;
ten Cate, Hugo ;
Prins, Martin H. ;
ten Cate-Hoek, Arina J. .
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2018, 2 (02) :299-309
[24]   Essential thrombophilia - Report of five cases [J].
Nygaard, KK ;
Brown, GE .
ARCHIVES OF INTERNAL MEDICINE, 1937, 59 (01) :82-106
[25]   D-dimer testing to determine the duration of anticoagulation therapy [J].
Palareti, Gualtiero ;
Cosmi, Benilde ;
Legnani, Cristina ;
Tosetto, Alberto ;
Brusi, Carlotta ;
Iorio, Alfonso ;
Pengo, Vittorio ;
Ghirarduzzi, Angelo ;
Pattacini, Corrado ;
Testa, Sophie ;
Lensing, Anthonie W. A. ;
Tripodi, Armando .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17) :1780-1789
[26]   A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis [J].
Poort, SR ;
Rosendaal, FR ;
Reitsma, PH ;
Bertina, RM .
BLOOD, 1996, 88 (10) :3698-3703
[27]   Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts [J].
Roach, R. E. J. ;
Lijfering, W. M. ;
Tait, R. C. ;
Baglin, T. ;
Kyrle, P. A. ;
Cannegieter, S. C. ;
Rosendaal, F. R. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (10) :1815-1822
[28]   Trends in the incidence of deep vein thrombosis and pulmonary embolism -: A 25-year population-based study [J].
Silverstein, MD ;
Heit, JA ;
Mohr, DN ;
Petterson, TM ;
O'Fallon, WM ;
Melton, LJ .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (06) :585-593
[29]   Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis [J].
van Vlijmen, E. F. W. ;
Wiewel-Verschueren, S. ;
Monster, T. B. M. ;
Meijer, K. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (07) :1393-1403
123